Figure 1: Percentages of HE4 and Ca72.4 positive patients at first diagnosis of ovarian epithelial cancer. A, represents the percentage of patients with elevated biomarker HE4; B, represents the percentage of patients with elevated biomarker CA72.4. Statistically significant difference was observed between HE4/ vs CA72.4 (* p< 0.02).